The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer (LAPC).
Heath Devin Skinner
No relevant relationships to disclose
Milind M. Javle
No relevant relationships to disclose
Robert A. Wolff
No relevant relationships to disclose
Marilyn V. Clemons
No relevant relationships to disclose
Mark F. Munsell
No relevant relationships to disclose
Marc E. Delclos
No relevant relationships to disclose
Jason B Fleming
No relevant relationships to disclose
Prajnan Das
Research Funding - Genentech
Christopher H. Crane
No relevant relationships to disclose
Sunil Krishnan
Research Funding - Genentech